Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.
Pannuti F, Martoni A, Di Marco AR, Piana E, Saccani F, Becchi G, Mattioli G, Barbanti F, Marra GA, Persiani W, Cacciari L, Spagnolo F, Palenzona D, Rocchetta G.
Pannuti F, et al. Among authors: mattioli g.
Eur J Cancer (1965). 1979 Apr;15(4):593-601. doi: 10.1016/0014-2964(79)90097-5.
Eur J Cancer (1965). 1979.
PMID: 86447
Clinical Trial.
No abstract available.